The global dual balloon angioplasty catheter market was valued at US$ 199.8 million in 2022. In 2023, this overall market value is projected to reach US$ 204.9 million. During the forecast year from 2023 to 2033, the global adoption of dual balloon angioplasty catheters could witness a CAGR of 3.2%. Furthermore, FMI predicts the global market to be valued at nearly US$ 281.3 million by the end of this forecast period. Growth is attributed to the increasing prevalence of cardiovascular disorders. Between 2018 and 2022, a CAGR of 2% was registered for the overall market.
Dual balloon angioplasty catheter is a medical device inserted into the artery to clear the blockage and allow the clogged blood to flow. Dual balloon angioplasty is done to prevent heart attack and angina in patients who have coronary artery disease.
Dual balloon angioplasty catheter is less invasive as compared to bypass surgery, which was the only option before. Balloon angioplasty widens the narrowed blood vessel by inflating the balloon, which expands the area in the artery. Dual balloon angioplasty catheter is a thin plastic and flexible tube with a tiny balloon, and its tip is used to inject fluids and measure blood pressure.
Sometimes, stents are inserted by placing them on the tip of the balloon in the dual balloon angioplasty to keep the artery wall expanded. X-ray is used in dual balloon angioplasty to guide the catheter into the heart and arteries. Dye is injected into the body to highlight the blood arteries. Dual balloon angioplasty catheter resolves the difficulties, such as insertion and removal of the large catheter.
Firm pressure is applied to the site of the catheter to stop the bleeding. Dual balloon angioplasty is usually done when the cholesterol plaque builds up in the wall of the artery of the heart, thus allowing more blood and oxygen to flow into the muscles of the heart.
| Attributes | Details |
|---|---|
| Global Dual Balloon Angioplasty Catheter Market Valuation in 2022 | US$ 199.8 million |
| Estimated Global Market Share in 2023 | US$ 204.9 million |
| Forecasted Global Market Size by 2033 | US$ 281.3 million |
| Projected Global Market Growth Rate from 2023 to 2033 | 3.2% CAGR |
| Historical Market Growth Rate from 2018 to 2022 | 2% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
A dual balloon angioplasty catheter is simple and easy. An increase in the prevalence of cardiac disorders and drugs can be delivered directly to the affected area by the soft and flexible catheter, which drives the market's growth.
The peripheral and coronary angioplasty market continues to grow in the coming years due to an increase in cardiovascular disease, obesity, and diabetes, boosting the growth of the overall market.
Due to some drawbacks of the procedure, less preference for dual balloon angioplasty by patients presents a considerable limitation to the growth of the dual-balloon angioplasty catheters market. Patients may need to perform a repeat procedure as the arteries eventually may get blocked several years after angioplasty.
| Category | By Indication |
|---|---|
| Top Segment | Coronary |
| Market Share in Percentage | 71.2% |
| Category | By End User |
|---|---|
| Top Segment | Hospital |
| Market Share in Percentage | 66.2% |
Principal Consultant
North America accounted for nearly 33.7% of the global market in 2022. Demand for balloon catheters may rise due to the presence of leading manufacturers, increased patient awareness, advanced healthcare facilities and infrastructure availability, and technological advancements.
The growth of the market in the region is attributed to the increasing awareness of treatment options and general health awareness in these regions, along with the impact of the rising prevalence of related illnesses.
To improve the existing products to get better results, some leading players in the region are focusing on novel product launches. They also invest extensively in research and development activities to develop advanced dual balloon angioplasty catheters.
| Regional Market Comparison | Global Market Share in Percentage |
|---|---|
| North America | 33.7% |
| Europe | 28.2% |
Europe accounted for almost 28.2% of the global market share in 2022. Growth in the region is underpinned by a growing aging population, efficient healthcare infrastructure, and an emphasis on the development of innovative technology and enhanced patient diagnosis.
Increasing minimally invasive surgical interventions, increased emphasis on research and development capabilities in medical devices and on the adoption of advanced healthcare technologies, an increase in robotic-assisted surgical procedures, and rising expenditure on healthcare infrastructure development are the key factors driving the growth of the market in this region.
| Regional Market Comparison | Global Market Share in Percentage |
|---|---|
| United States | 31% |
| Germany | 8.2% |
| Japan | 7.1% |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The Asia Pacific is anticipated to gain market share during the forecast period. Product launches, acquisitions, distribution agreements, alliances, and geographical expansion by local players, especially in China and India, are expected to propel the region's dual balloon angioplasty catheter market.
The fast pace of growth of this regional market can also be attributed to growing consciousness regarding Percutaneous Coronary Intervention (PCI) procedures, coupled with the increasing adoption of cost-effective and minimally-invasive methods.
Manufacturers in the dual balloons angioplasty catheter market are looking to cash in on this trend and establish themselves in APAC to gain a stronger foothold in the global angioplasty balloons market.
| Regional Markets | CAGR (2023 to 2033) |
|---|---|
| United Kingdom | 2.2% |
| China | 3.9% |
| India | 3.2% |
| Australia | 2.8% |
The new entrants in the dual balloon angioplasty catheter market continually indulge in collaborations and highly invest in research and development activities to provide more convenient solutions to industry verticals. Some leading start-ups that are leading the development of the market are – Manishmedi Innovation, Advin Health Care, and Ridgeback Technologies Private Limited
Ridgeback Technology Private Ltd. specializes in designing, developing, and manufacturing leading-edge catheter balloons.
Key participants in the global dual balloon angioplasty catheter market include Spectranetics, InSitu Technologies Inc, eucatech AG, Balton Sp. z o.o., PanMed Us, Degania Silicone Ltd, Van Oostveen Medical B.V., IMeSI, phenox GmbH, Natec Medical, Acrostak Int., and SCITECH, Medinol Ltd. among others.
The market is highly competitive due to the presence of such leading participants. While global players such as Spectranetics, InSitu Technologies Inc, eucatech AG, Balton Sp. z o.o., PanMed Us, and Degania Silicone Ltd account for a considerable market size, and several regional-level players are also operating across key growth regions, particularly in the Asia Pacific.
In May 2020 - Zavation Medical Products, an innovative designer and manufacturer of high-quality spinal implants, instruments, MIS procedural kits, and biologics headquartered in Flowood, MS, announced the launch of eZspand, an expandable lumbar interbody fusion device.
| Attributes | Details |
|---|---|
| Growth Rate | CAGR of 3.2% from 2023 to 2033 |
| Expected Market Value (2023) | US$ 204.9 million |
| Anticipated Forecast Value (2033) | US$ 281.3 million |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered | Indication, End User, Region |
| Regions Covered | North America; Latin America; Europe; Asia Pacific; The Middle East and Africa |
| Key Countries Profiled | United States, Canada, Mexico, Brazil, Germany, France, United Kingdom, Spain, China, Japan, South Korea, GCC, South Africa, Israel |
| Key Companies Profiled | Spectranetics; InSitu Technologies Inc.; Eucatech AG; Balton Sp. z o.o.; PanMed; Degania Silicone Ltd; Romed Holland; IMeSI; phenox GmbH; Natec Medical; Acrostak; SCITECH; Medinol Ltd. |
| Customization & Pricing | Available Upon Request |
The United States, India, and Germany dominate the global market.
The market is forecast to register a CAGR of 3.2% through 2033.
From 2018 to 2022, the market registered a CAGR of 2%.
Technological advancement disrupts the current market trends.
The global market size is to reach US$ 281.3 million by 2033.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Indication, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Indication, 2023 to 2033 5.3.1. Peripheral 5.3.2. Coronal 5.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End–User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End–User, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End–User, 2023 to 2033 6.3.1. Hospitals 6.3.2. Catheterization Labs 6.4. Y-o-Y Growth Trend Analysis By End–User, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By End–User, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022 7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Western Europe 7.3.4. Eastern Europe 7.3.5. South Asia and Pacific 7.3.6. East Asia 7.3.7. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 8.2.1. By Country 8.2.1.1. The USA 8.2.1.2. Canada 8.2.2. By Indication 8.2.3. By End–User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Indication 8.3.3. By End–User 8.4. Key Takeaways 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Indication 9.2.3. By End–User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Indication 9.3.3. By End–User 9.4. Key Takeaways 10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. United Kingdom 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Western Europe 10.2.2. By Indication 10.2.3. By End–User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Indication 10.3.3. By End–User 10.4. Key Takeaways 11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Poland 11.2.1.2. Russia 11.2.1.3. Czech Republic 11.2.1.4. Romania 11.2.1.5. Rest of Eastern Europe 11.2.2. By Indication 11.2.3. By End–User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Indication 11.3.3. By End–User 11.4. Key Takeaways 12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Bangladesh 12.2.1.3. Australia 12.2.1.4. New Zealand 12.2.1.5. Rest of South Asia and Pacific 12.2.2. By Indication 12.2.3. By End–User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Indication 12.3.3. By End–User 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Indication 13.2.3. By End–User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Indication 13.3.3. By End–User 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Indication 14.2.3. By End–User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Indication 14.3.3. By End–User 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. USA 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2022 15.1.2.1. By Indication 15.1.2.2. By End–User 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2022 15.2.2.1. By Indication 15.2.2.2. By End–User 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2022 15.3.2.1. By Indication 15.3.2.2. By End–User 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2022 15.4.2.1. By Indication 15.4.2.2. By End–User 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2022 15.5.2.1. By Indication 15.5.2.2. By End–User 15.6. United Kingdom 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2022 15.6.2.1. By Indication 15.6.2.2. By End–User 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2022 15.7.2.1. By Indication 15.7.2.2. By End–User 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2022 15.8.2.1. By Indication 15.8.2.2. By End–User 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2022 15.9.2.1. By Indication 15.9.2.2. By End–User 15.10. Poland 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2022 15.10.2.1. By Indication 15.10.2.2. By End–User 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2022 15.11.2.1. By Indication 15.11.2.2. By End–User 15.12. Czech Republic 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2022 15.12.2.1. By Indication 15.12.2.2. By End–User 15.13. Romania 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2022 15.13.2.1. By Indication 15.13.2.2. By End–User 15.14. India 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2022 15.14.2.1. By Indication 15.14.2.2. By End–User 15.15. Bangladesh 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2022 15.15.2.1. By Indication 15.15.2.2. By End–User 15.16. Australia 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2022 15.16.2.1. By Indication 15.16.2.2. By End–User 15.17. New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2022 15.17.2.1. By Indication 15.17.2.2. By End–User 15.18. China 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2022 15.18.2.1. By Indication 15.18.2.2. By End–User 15.19. Japan 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2022 15.19.2.1. By Indication 15.19.2.2. By End–User 15.20. South Korea 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2022 15.20.2.1. By Indication 15.20.2.2. By End–User 15.21. GCC Countries 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2022 15.21.2.1. By Indication 15.21.2.2. By End–User 15.22. South Africa 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2022 15.22.2.1. By Indication 15.22.2.2. By End–User 15.23. Israel 15.23.1. Pricing Analysis 15.23.2. Market Share Analysis, 2022 15.23.2.1. By Indication 15.23.2.2. By End–User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Indication 16.3.3. By End–User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Spectranetics 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. InSitu Technologies® Inc. 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. Eucatech AG 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. Balton Sp. z o.o. 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. PanMed 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. Degania Silicone Ltd 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 17.1.7. Romed Holland 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.7.5.2. Product Strategy 17.1.7.5.3. Channel Strategy 17.1.8. IMeSI 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.8.5.2. Product Strategy 17.1.8.5.3. Channel Strategy 17.1.9. phenox GmbH 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.9.5.2. Product Strategy 17.1.9.5.3. Channel Strategy 17.1.10. Natec Medical 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.10.5.2. Product Strategy 17.1.10.5.3. Channel Strategy 17.1.11. Acrostak 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.11.5.2. Product Strategy 17.1.11.5.3. Channel Strategy 17.1.12. SCITECH 17.1.12.1. Overview 17.1.12.2. Product Portfolio 17.1.12.3. Profitability by Market Segments 17.1.12.4. Sales Footprint 17.1.12.5. Strategy Overview 17.1.12.5.1. Marketing Strategy 17.1.12.5.2. Product Strategy 17.1.12.5.3. Channel Strategy 17.1.13. Medinol Ltd. 17.1.13.1. Overview 17.1.13.2. Product Portfolio 17.1.13.3. Profitability by Market Segments 17.1.13.4. Sales Footprint 17.1.13.5. Strategy Overview 17.1.13.5.1. Marketing Strategy 17.1.13.5.2. Product Strategy 17.1.13.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Healthcare
June 2023
REP-GB-12575
220 pages
Explore Healthcare Insights
View Reports
Dual Balloon Angioplasty Catheter Market
